KALARIS THERAPEUTICS, INC. Common Stock, Capital Shares Reserved for Future Issuance
KALARIS THERAPEUTICS, INC. (KLRS) had Common Stock, Capital Shares Reserved for Future Issuance of 4.67 million shares as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Class of Stock Disclosures
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-11
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 4.67M shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 5.48M shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 4.37M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 3.59M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2026-06-30 | 4.67M shares 10-Q · filed 2026-08-11 | |
| 2026-03-31 | 5.48M shares 10-Q · filed 2026-05-12 | |
| 2025-12-31 | 4.37M shares 10-Q · filed 2026-08-11 | |
| 2025-09-30 | 3.59M shares 10-Q · filed 2025-11-12 | |
| 2025-06-30 | 3.60M shares 10-Q · filed 2025-08-13 | |
| 2025-03-31 | 3.60M shares 10-Q · filed 2025-05-14 | |
| 2024-12-31 | 10.07M shares 10-K · filed 2026-03-17 | 1.02M shares 10-K · filed 2025-03-07 |
| 2024-09-30 | 23.87M shares 10-Q · filed 2024-11-12 | |
| 2024-06-30 | 23.99M shares 10-Q · filed 2024-08-09 | |
| 2024-03-31 | 22.85M shares 10-Q · filed 2024-05-13 | |
| 2023-12-31 | 798.14K shares 10-K · filed 2025-03-07 | 18.36M shares 10-K · filed 2024-03-15 |
| 2023-09-30 | 18.54M shares 10-Q · filed 2023-11-02 | |
| 2023-06-30 | 18.79M shares 10-Q · filed 2023-08-03 | |
| 2023-03-31 | 19.08M shares 10-Q · filed 2023-05-04 | |
| 2022-12-31 | 14.87M shares 10-K · filed 2024-03-15 | |
| 2022-09-30 | 15.34M shares 10-Q · filed 2022-11-03 | |
| 2022-06-30 | 15.73M shares 10-Q · filed 2022-08-04 | |
| 2022-03-31 | 15.66M shares 10-Q · filed 2022-05-05 | |
| 2021-12-31 | 13.45M shares 10-K · filed 2023-02-15 | 12.83M shares 10-K · filed 2022-02-10 |
| 2021-09-30 | 13.22M shares 10-Q · filed 2021-11-05 | |
| 2021-06-30 | 13.66M shares 10-Q · filed 2021-08-06 | |
| 2021-03-31 | 14.02M shares 10-Q · filed 2021-05-06 | |
| 2020-12-31 | 11.28M shares 10-K · filed 2022-02-10 | |
| 2020-09-30 | 11.55M shares 10-Q · filed 2020-11-10 | |
| 2020-06-30 | 44.09M shares 10-Q · filed 2020-09-02 | |
| 2019-12-31 | 44.79M shares 10-K · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |